Back to Programme

Biotechnologies for the Diagnosis and Treatment of Autoimmune Diseases

February, 13
16:00–17:30
In partnership with R-pharm
Biotechnologies in Personalized Healthcare, Including Active Longevity and Preventive Medicine Technologies
World Trade Center Moscow, entrance No. 4, 1st floor, conference hall No. 2. Gazprombank
Autoimmune diseases are a significant challenge for medical science. Due to the fact that these diseases cause premature disability and an unfavourable life prognosis for patients (economic losses are comparable to those incurred when fighting cancer), they carry great social significance. In last decade, there has been a tendency towards an increase in the frequency of autoimmune pathologies, at a time when existing methods for treating such diseases are not able to deal with the root causes of autoimmune destruction, and are instead only focused on eliminating the consequences. Recently, Russian scientists staged a coup in the study and treatment of autoimmune diseases – the development in Russia of a unique, fundamentally new approach in pharmacotherapy of autoimmune pathologies that can become a platform for future treatments of a wide range of diseases from this group, in particular type I diabetes, which mainly manifests in children. How are innovative discoveries in autoimmunology changing the face of today’s medicine and how far has medical science advanced in the study of autoimmune diseases? Are there prerequisites for individualizing the treatment of AIDs as part of the concept of personalized medicine? What are the prospects for the further integration of innovative solutions in treating autoimmune diseases and in hands-on healthcare?
Moderator:
Aleksandr Lila
Director, V.A. Nasonova Research Institute of Rheumatology; Chief Freelance Specialist Rheumatologist of the Ministry of Health of the Russian Federation
Panellists:
Natalia Mokrysheva
Director, Head of the Department of Personalized and Translational Medicine, National Medical Research Center of Endocrinology, Ministry of Health of the Russian Federation; Corresponding Member of the Russian Academy of Sciences
Evgeny Nasonov
Academic Director, V.A. Nasonova Research Institute of Rheumatology
Mikhail Samsonov (online)
Chief Medical Officer, R Pharm
Ekaterina Troshina
Deputy Director – Director of the Institute of Clinical Endocrinology, National Medical Research Center for Endocrinology of the Ministry of Health of the Russian Federation
Dmitry Chudakov
Acting Director, Research Institute of Translational Medicine, N.I. Pirogov Russian National Research Medical University
Pavel Yakovlev
Deputy General Director for Early Development and Research of a Biotechnology Company, BIOCAD
трансляция